Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 3 de 3
Filtrer
Plus de filtres










Base de données
Gamme d'année
1.
Mar Drugs ; 13(4): 2030-45, 2015 Apr 13.
Article de Anglais | MEDLINE | ID: mdl-25871286

RÉSUMÉ

A set of fluorophenoxyanilides, designed to be simplified analogues of previously reported ω-conotoxin GVIA mimetics, were prepared and tested for N-type calcium channel inhibition in a SH-SY5Y neuroblastoma FLIPR assay. N-type or Cav2.2 channel is a validated target for the treatment of refractory chronic pain. Despite being significantly less complex than the originally designed mimetics, up to a seven-fold improvement in activity was observed.


Sujet(s)
Analgésiques non narcotiques/pharmacologie , Anilides/pharmacologie , Inhibiteurs des canaux calciques/pharmacologie , Canaux calciques de type N/métabolisme , Conception de médicament , Protéines de tissu nerveux/antagonistes et inhibiteurs , Neurones/effets des médicaments et des substances chimiques , Analgésiques non narcotiques/synthèse chimique , Analgésiques non narcotiques/composition chimique , Analgésiques non narcotiques/métabolisme , Anilides/synthèse chimique , Anilides/composition chimique , Anilides/métabolisme , Fixation compétitive , Inhibiteurs des canaux calciques/synthèse chimique , Inhibiteurs des canaux calciques/composition chimique , Inhibiteurs des canaux calciques/métabolisme , Canaux calciques de type N/composition chimique , Signalisation calcique/effets des médicaments et des substances chimiques , Lignée cellulaire tumorale , Fluorobenzènes/synthèse chimique , Fluorobenzènes/composition chimique , Fluorobenzènes/métabolisme , Fluorobenzènes/pharmacologie , Tests de criblage à haut débit , Humains , Structure moléculaire , Thérapie moléculaire ciblée , Protéines de tissu nerveux/métabolisme , Névralgie/traitement médicamenteux , Névralgie/métabolisme , Neurones/métabolisme , Neurotoxines/composition chimique , Douleur rebelle/traitement médicamenteux , Douleur rebelle/métabolisme , Relation structure-activité , Conotoxine-oméga-GVIA/composition chimique , Conotoxine-oméga-GVIA/métabolisme , Conotoxine-oméga-GVIA/pharmacologie
2.
Biomaterials ; 33(30): 7631-42, 2012 Oct.
Article de Anglais | MEDLINE | ID: mdl-22831854

RÉSUMÉ

In this work a series of ABA tri-block copolymers was prepared from oligo(ethylene glycol) methyl ether methacrylate (OEGMA(475)) and N,N-dimethylaminoethyl methacrylate (DMAEMA) to investigate the effect of polymer composition on cell viability, siRNA uptake, serum stability and gene silencing. Reversible Addition-Fragmentation Chain Transfer (RAFT) polymerization was used as the method of polymer synthesis as this technique allows the preparation of well-defined block copolymers with low polydispersity. Eight block copolymers were prepared by systematically varying the central cationic block (DMAEMA) length from 38 to 192 monomer units and the outer hydrophilic block (OEGMA(475)) from 7 to 69 units. The polymers were characterized using size exclusion chromatography and (1)H NMR. Chinese Hamster Ovary-GFP and Human Embryonic Kidney 293 cells were used to assay cell viability while the efficiency of block copolymers to complex with siRNA was evaluated by agarose gel electrophoresis. The ability of the polymer-siRNA complexes to enter into cells and to silence the targeted reporter gene enhanced green fluorescent protein (EGFP) was measured by using a CHO-GFP silencing assay. The length of the central cationic block appears to be the key structural parameter that has a significant effect on cell viability and gene silencing efficiency with block lengths of 110-120 monomer units being the optimum. The ABA block copolymer architecture is also critical with the outer hydrophilic blocks contributing to serum stability and overall efficiency of the polymer as a delivery system.


Sujet(s)
Cations/composition chimique , Extinction de l'expression des gènes , Techniques de transfert de gènes , Polymérisation , Polymères/composition chimique , Animaux , Cellules CHO , Survie cellulaire , Chromatographie sur gel , Cricetinae , Électrophorèse sur gel d'agar , Cellules HEK293 , Humains , Microscopie à force atomique , Masse moléculaire , Nanoparticules/ultrastructure , Polyéthylène glycols/composition chimique , Polymères/synthèse chimique , Petit ARN interférent/métabolisme , Sérum/métabolisme
3.
Bioorg Med Chem ; 17(18): 6659-70, 2009 Sep 15.
Article de Anglais | MEDLINE | ID: mdl-19683451

RÉSUMÉ

A number of omega-conotoxin GVIA mimetics based on an anthranilamide core were prepared and tested for their affinity for rat brain Ca(v)2.2 channels. Features such as the presence of hydroxyl and fluoro substituents on the tyrosine side chain mimic, the length of the chains on the lysine/arginine side chain mimics and the use of diguanidino and diamino substituents rather than mono-guanidine/mono-amine substitution were examined. The diguanidinylated compounds proved to be the most active and deletion of the hydroxyl substituent had a limited influence on activity. The SAR associated with variation in the lysine/arginine side chain mimics was not strong. The introduction of a fluoro substituent into the tyrosine mimic produced the most active compound prepared in this study (2g), with an EC(50) at rat brain Ca(v)2.2 channels of 6 microM.


Sujet(s)
Inhibiteurs des canaux calciques/composition chimique , Inhibiteurs des canaux calciques/pharmacologie , Canaux calciques de type N/métabolisme , Conotoxine-oméga-GVIA/composition chimique , Conotoxine-oméga-GVIA/pharmacologie , ortho-Aminobenzoates/composition chimique , Animaux , Encéphale/métabolisme , Liaison aux protéines , Rats , Relation structure-activité
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE